0001214659-19-002152.txt : 20190318 0001214659-19-002152.hdr.sgml : 20190318 20190315214526 ACCESSION NUMBER: 0001214659-19-002152 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190318 DATE AS OF CHANGE: 20190315 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NEWLINK GENETICS CORP CENTRAL INDEX KEY: 0001126234 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421491350 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-86491 FILM NUMBER: 19686637 BUSINESS ADDRESS: STREET 1: 2503 SOUTH LOOP DRIVE STREET 2: SUITE 5100 CITY: AMES STATE: IA ZIP: 50010 BUSINESS PHONE: 515-296-5555 MAIL ADDRESS: STREET 1: 2503 SOUTH LOOP DRIVE STREET 2: SUITE 5100 CITY: AMES STATE: IA ZIP: 50010 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: 1Globe Capital LLC CENTRAL INDEX KEY: 0001562189 IRS NUMBER: 800841812 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 333 PROVIDENCE HIGHWAY CITY: BOSTON STATE: MA ZIP: 02062 BUSINESS PHONE: 5148398866 MAIL ADDRESS: STREET 1: 333 PROVIDENCE HIGHWAY CITY: BOSTON STATE: MA ZIP: 02062 SC 13G/A 1 g315191sc13ga1.htm AMENDMENT NO. 1

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

SCHEDULE 13G/A

 

Under the Securities Exchange Act of 1934

(Amendment No. 1 )*

 

NewLink Genetics Corporation
(Name of Issuer)
 
Common Stock, $0.01 par value
(Title of Class of Securities)

 

  651511107  
  (CUSIP Number)  
 
December 31, 2018
(Date of Event Which Requires Filing of This Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

    Rule 13d-1(b)
     
    Rule 13d-1(c)
     
    Rule 13d-1(d)

 

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 1  
 

 

CUSIP No.  651511107
1

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

1Globe Capital LLC

80-0841812

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

 

 

(a) 

(b) 

3

SEC USE ONLY

 

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH REPORTING

PERSON WITH:

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

0

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.00%

12

TYPE OF REPORTING PERSON (see instructions)

 

OO

 

 2  
 

 

Item 1(a). Name of Issuer:
   
   NewLink Genetics Corporation
   
Item 1(b). Address of Issuer’s Principal Executive Offices:
   
  

2503 South Loop Drive

Ames, IA 50010

   
Item 2(a). Name of Person Filing:
   
   1Globe Capital LLC
   
Item 2(b). Address of Principal Business Office or, if none, Residence:
     
  

One International Place, Suite 4420

Boston, MA 02110

   
Item 2(c). Citizenship:
   
   See Item 4 on the cover page.
   
Item 2(d). Title of Class of Securities:
   
   Common Stock, $0.01 par value
   
Item 2(e). CUSIP Number:  651511107

 

 3  
 

 

Item 3. If this Statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
  (a)   Broker or dealer registered under Section 15 of the Act;
  (b)   Bank as defined in Section 3(a)(6) of the Act;
  (c)   Insurance company as defined in Section 3(a)(19) of the Act;
  (d)   Investment company registered under Section 8 of the Investment Company Act of 1940;
  (e)   An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
  (f)   An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
  (g)   A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
  (h)   A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i)   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
  (j)   A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
  (k)   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:      

 

Item 4. Ownership.
  Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
   (a) Amount Beneficially Owned: 0    
   (b) Percent of Class: 0.00%
   (c) Number of shares as to which such person has:
      (i) sole power to vote or to direct the vote: 0    
      (ii) shared power to vote or to direct the vote: 0   
      (iii) sole power to dispose or to direct the disposition of: 0    
      (iv) shared power to dispose or to direct the disposition of: 0   

 

 4  
 

 

Item 5. Ownership of Five Percent or Less of a Class.
   
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.
   
 Item 6. Ownership of More than Five Percent on Behalf of Another Person.
   
  Not applicable.
   
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
   
  Not applicable.
   
Item 8. Identification and Classification of Members of the Group.
   
  Not applicable.
   
Item 9. Notice of Dissolution of Group.
   
  Not applicable.
   
Item 10. Certification.
   
  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of and do not have the effect of changing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect for the time being.

 

 5  
 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  March 15, 2019  
  Date  
     
  /s/ Linda Li  
  Signature  
     
  Linda Li, Managing Director  
  Name/Title  

 

 

 6